Science & Technology
Mon, January 9, 2012Sun, January 8, 2012Sat, January 7, 2012Fri, January 6, 2012Thu, January 5, 2012Wed, January 4, 2012Tue, January 3, 2012Mon, January 2, 2012Sat, December 31, 2011Fri, December 30, 2011BT Signs Multi-Year, Managed Services Contract with Bristol-Myers Squibb
//science-technology.news-articles.net/content/2 .. services-contract-with-bristol-myers-squibb.html
Published in Science and Technology on Thursday, January 5th 2012 at 5:16 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
BT Signs Multi-Year, Managed Services Contract with Bristol-Myers Squibb -- IRVING, Texas, Jan. 5, 2012 /PRNewswire/ --
BT Signs Multi-Year, Managed Services Contract with Bristol-Myers Squibb
IRVING, Texas, Jan. 5, 2012 /PRNewswire/ -- BT (NYSE: BT) today announced that it has signed a contract extension with Bristol-Myers Squibb to manage its global network services through 2017.
BT will help Bristol-Myers Squibb derive greater value from its network services through increased standardization and innovation. The contract extension covers outsourced networked services, including wide area and local area networks, as well as remote access, voice, and telephony infrastructure. It also includes sector leading compliance management tailored to the requirements of the pharmaceutical industry, and network security services. The contract extension is global in scope, covering all of Bristol-Myers Squibb locations.
"Working with Bristol-Myers Squibb isn't just about managing technology; it's about assuring highly reliable services that enable collaboration and communication," said Bas Burger, president Global Commerce in BT Global Services. "The needs of the pharmaceutical sector are complex, specific and submitted to stringent compliance requirements. When organizations remain focused on driving their business without worrying about technology, then we have done our job."
Rick Yborra, vice president, Network and Hosting Services at Bristol-Myers Squibb added: "The partnership we have built with BT is based on our confidence in their global operational capabilities and their ability to flex with our changing needs. BT provides us with the type of world-class network that is necessary for a global BioPharma company to operate effectively."
The first contract between BT and Bristol-Myers Squibb was signed in 2005.
About BT
BT is one of the world's leading providers of communications services and solutions, serving customers in more than 170 countries. Its principal activities include the provision of networked IT services globally; local, national and international telecommunications services to our customers for use at home, at work and on the move; broadband and internet products and services and converged fixed/mobile products and services. BT consists principally of four lines of business: BT Global Services, BT Retail, BT Wholesale and Openreach.
In the year ended 31 March 2011, BT Group's revenue was 20,076m pounds Sterling with profit before taxation of 1,717m pounds.
British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group. BT Group plc is listed on stock exchanges in London and New York.
For more information, visit [ www.btplc.com ].
All news releases can be accessed at our web site: [ http://www.btplc.com/news ]
SOURCE BT
[ Back to top ] RELATED LINKS
[ http://www.btplc.com ]
